                         SEQUENCE LISTING

<110>  Schmitt, et al.
 
<120>  Dosages of GIP/GLP-1 Co-Agonist Peptides for Human Administration

<130>  31812/47965A

<150>  61/875,686
<151>  2013-09-09

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Wild type glucagon

<400>  1

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C12-C20 fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  4
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C12 fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  4

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  5
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C14 fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  5

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  6
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C16 fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  6

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  7
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<220>
<221>  mod_res
<222>  (2)..(2)
<223>  Aib

<220>
<221>  mod_res
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C18 fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  7

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  8
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  mod_res
<222>  (2)..(2)
<223>  Aib

<220>
<221>  mod_res
<222>  (20)..(20)
<223>  Aib

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C20 fatty acyl group covalently attached to Lysine

<220>
<221>  misc_feature
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  8

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


